|
CMI
shuts shop in India; suspends global operations
Germany-based phytopharmaceutical company Centers for Medical
Innovation (CMI) has suspended its global operations owing to severe
financial crisis.
Zandu
puts Parkinson’s drug studies on hold
The future of HP-200, Zandu’s investigational new drug
for the treatment of Parkinson’s disease, has suffered a set-back
with CMI suspending all development work on the molecule owing to
severe financial crisis.
Alkem
takes a plunge into R&D biz with CRO arm
The Mumbai-based Alkem Laboratories has set up a contract research
centre in an effort to kick-start its R&D programme.
|
